Atlas Trials

A Study Evaluating the Safety and Efficacy of Tirofiban in Combination With Alteplase in Acute Ischemic Stroke

Clinical trial NCT05188417 · UNKNOWN

Trial details

NCT number
NCT05188417
Sponsor
GrandPharma (China) Co., Ltd.
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Acute Ischemic Stroke
Start date
2021-12-09
Primary completion
2023-03-30
Enrollment
266

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.